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ABSTRACT 
Dyskeratosis congenita is a rare genetic disorder that causes a variety of 
symptoms, including mucocutaneous features, stem cell dysfunction, telomere 
shortening, ribosomal failure and increased susceptibility to cancer. The 
disease may have either autosomal dominant/recessive or X-linked inheritance. 
The X-linked form, that is the most common, is caused by mutations of the 
DKC1 gene. Loss-of-function mutations of this gene, which encodes the 
nucleolar protein dyskerin, affect telomere stability, ribosome biogenesis, RNA 
pseudouridylation and production of small nucleolar RNA-derived micro 
RNAs. Dyskerin participates in fact to at least two essential ribonucleoprotein 
complexes: the H/ACA small nucleolarRNP complex, involved in rRNA 
processing and in the pseudouridylation of cellular RNAs, and the telomerase 
active complex, involved in telomere stability.  
A single DKC1 ubiquitary transcript has been described to date. However, the 
wide spectrum of functions in which the gene has been involved raised the 
possibility that alternative transcripts with different coding properties might 
also exist. Since a more extensive analysis of the DKC1 may have shed light on 
the molecular mechanisms underlying the multiple functions accomplished by 
this gene and suggest new approaches for the therapy, I performed a detailed 
analysis of the gene transcriptional activity.  
Here I show that at least 5 alternative transcripts, with different tissue 
expression profiles and coding potentials, derive from the DKC1 gene. 
Intriguingly, these transcripts are differentially tuned during in-vitro 
differentiation of Caco-2 and SK-N-BE(2) cells and, although they present 
premature stop codons, all escape the mRNA control mediated by Nonsense 
Mediated Decay, which usually reduces the accumulation of aberrant 
transcripts.  
In my thesis I also report the results obtained after constitutive overexpression 
in HeLa cells of one of the most interesting newly identified DKC1 mRNAs, 
called Isoform 7. This isoform encodes a variant protein that is identical to 
canonical dyskerin but lacks the C-terminal NLS signal and is specifically -and 
unexpectedly- localized in the cytoplasm. Since both types of dyskerin-
participated ribonucleoprotein complexes are strictly localized in the nucleus, 
the biological role of this variant protein is puzzling, but compatible with the 
hypothesis that it may be directly involved in the translation process or in 
transport of the small nucleolar RNA derived micro RNAs from the nucleus to 
the cytoplasm. Intriguingly, Isoform 7 overexpression in stable transformed 
cells resulted in alteration of cell morphology, increased cell-cell and cell-
matrix adhesion, higher proliferation rate and increased survival after X-ray 
irradiation. Altogether, the results obtained indicated that DKC1 gene 
expression is more complex than generally accepted, and that previously 
undetected alternative splice transcripts may be responsible, at least in part, for 
the plethora of different manifestations of the X-linked DC. 
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1. BACKGROUND 
1.1. DYSKERATOSIS CONGENITA: A MULTISYSTEMIC AND 
GENETICALLY HETEROGENEOUS SYNDROME 
Dyskeratosis congenita (DC) is a rare multi-systemic 
disorder characterized by heterogeneous clinical presentation and different 
inheritance modes. Oral leukoplakia, nail dystrophy and reticular hyper 
pigmentation of the skin compose a triad of mucocutaneous symptoms typical 
of this disease. The disease also causes premature aging, susceptibility to 
cancer, pulmonary diseases, osteoporosis, and bone marrow failure, with the 
latter representing the main cause of death. The disease strongly correlates with 
telomere shortening and stem cell dysfunction (for a review Kirwan and Dokal 
2009).  
 
Figure 1. Main 
mucocutaneous 
features of 
Dyskeratosis 
Congenita. 
 
 
 
 
 
 
 
 
 
Table 1. Somatic abnormalities and complications in patients with Dyskeratosis 
Congenita (Walne et al. 2005). 
 Abnormality Patients, % 
Classic presentation Abnormal skin pigmentation 89 
 Nail dystrophy 88 
 Bone marrow failure 85,5 
 Leukoplakia 78 
Other common 
features 
Epiphora 30,5 
 
Learning difficulties/developmental 
delay/mental retardation 
25,4 
 Pulmonary disease 20,3 
 Short stature 19,5 
 Extensive dental caries/loss 16,9 
 Esophageal stricture 16,9 
 Esophageal stricture 16,1 
 Hyperhiderosis 15,3 
 Malignancy 9,8 
The disease exhibit genetic heterogeneity, with three kinds of inheritance 
modes: Autosomal Dominant (AD-DC), Autosomal Recessive (AR-DC) and X 
linked (X-DC), with Hoyeraal-Hreidarsson syndrome (HHS) now considered 
an allelic X-DC severe form. 
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Six causative genes have been so far identified. Out of them, three have been 
associated with AD-DC (MIM #127550), the milder form of the disease 
(Scoggins et al. 1971) characterized by generation anticipation. These genes 
include the telomerase RNA component gene (TERC; Fogarty et al. 2003), the 
telomerase reverse transcriptase (TERT; Armanios et al. 2005) and the TRF-1 
interacting nuclear factor 2 (TINF2; Walne et al. 2008). 
AR-DC (MIM #224230), first described by Costello and Buncke (1956), has 
been the most elusive form of the disease, with the NOP10 (Walne et al. 2007) 
and the NHP2 (Vulliamy et al. 2008) causative genes identified only recently. 
X-DC (MIM #305000) represents the most diffuse and severe form of 
congenital dyskeratosis. Firstly identified by Bryan and Nixon (1965), this 
form is caused by mutations in the DKC1 gene (Heiss et al. 1998), which 
encodes a nucleolar protein named dyskerin. Some DKC1 mutations are also 
causative of HHS (MIM #300240), now recognized as a severe form of X-DC. 
In HHS patients, aplastic anemia, immunodeficiency, microcephaly, cerebellar 
hypoplasia, and fetal growth retardation are added to the classical X-DC 
symptoms. 
More than 40 mutations affecting the DKC1 gene have been so far identified, 
including an in frame triplet deletion (201-203 CTT) that generates the deletion 
of the aminoacid leucin 37 (Heiss et al. 1998); a ~2 kb (kilo bases) 
chromosomal deletion that causes the loss of exon 15 and the use of a cryptic 
polyadenilation signal (Vulliamy et al. 1999); a single mutation into the 
promoter region (-141; C→G) that disrupts a binding site of the transcription 
factor SP1, thus affecting the basal level of the promoter (Knight et al. 2001); a 
mutation in intron 1 (IVS1+592; C→G), that generates a cryptic donor splice 
site which brings to the incorporation into the mature transcript of 246 intronic 
bases that interrupt the CDS (CoDing Sequence) and generate a non functional 
transcript (Knight et al. 2001). Dyskerin mutations are mostly missense and are 
dispersed along the sequence, although mainly localized in the N-terminal 
region upstream the TruB_N domain (TruB family pseudouridylate synthase 
N-terminal domain), or in 300-400 aa region, corresponding to the PUA 
(Pseudouridine synthase and Archaeosine transglycosylase) RNA binding 
domain (see Fig. 2c). Very recently, two new mutations have been identified: a 
two bases inversion in exon 3 (166-167invCT; Kurnikova et al. 2009), and a 
novel mutation within intron 12 (IVS12+1; G→A; Pearson et al. 2008). 
Strikingly, the latter disrupts the intron donor splice site and is predicted to lead 
to intron 12 retention, an event that would generate a truncated protein 
retaining all the functional domains with the exception of the C-terminal NLS 
(Nuclear/Nucleolar Localization Signal). 
Dyskerin, the protein encoded by the DKC1 gene, belongs to a family highly 
conserved from Archaea to mammals. Members of this family are named 
Cbf5p in yeast, trypanosomes and Archaea; Minifly/Nop60B in Drosophila, 
NAP57 in rat and dyskerin in mouse. In eukaryotes, proteins of this family 
accumulate mainly into nucleoli and are involved in several essential 
processes, such as ribosomal RNAs (rRNA) maturation, rRNA and 
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spliceosomal small nuclear RNAs (snRNA) pseudouridylation and, at least in 
mammals, also the maintenance of telomere integrity.  
 
Figure 2. Inheritance mode of DC (modified from Marrone et al. 2005). 
In a) Venn diagram summarizing DC inheritance modes. Aplastic anemia (AA), myelodysplastic 
syndromes (MDS), paroxysmal nocturnal haemoglobinuria (PNH) Dyskeratosis congenital (DC) 
or Hoyeraal-Hreidarsson (HH); in red ,mutations of the TERC gene. b) Mutations in DKC1 non 
coding regions; in italics, below, known polymorphisms c) Mutations in DKC1 coding regions; in 
bold, mutations causing HH; * mutations recurring in more than one family. 
The DKC1 gene is divided into 15 exons and hosts two snoRNAs (small 
nucleolar RNA) of the H/ACA class, named ACA36 and ACA56 in intron 8 
and 12, respectively. Both snoRNAs have verified targets on rRNAs (see Fig. 
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3a). In addition, ACA56 is known to act as a micro RNA (miRNA) precursor 
(Ender et al. 2008). 
The Pfam databank (http://pfam.sanger.ac.uk/ accession O60832, 
DKC1_HUMAN) identifies within human dyskerin three different domains. 
The DKLD (Dyskerin-like domain, 48-106 aa) with unknown function, but 
typical of this protein family; the TruB_N the pseudouridine synthase catalytic 
domain, harboring the conserved aspartic 125, which marks the active site 
(110-226 aa), and the PUA RNA binding domain (297-370 aa). In addition, 
four low complexity regions (aa 11-20, 421-455, 467-480, 498-507), rich in 
lysine and arginine, are identified within the bipartite NLSs (see Fig. 3b). Their 
high level of evolutionary conservation further testifies the importance of 
proteins belonging to the dyskerin family. For instance, the human dyskerin 
and its Drosophila homologue, the MFL protein, share 66% of identity and 
79% of similarity (Giordano et al. 1999). 
Many post translational modification of human dyskerin have been annotated 
by the UniProt database (http://www.uniprot.org/ accession O60832, 
DKC1_HUMAN): the elimination of initiator methionine, the acetyation of 
alanine 2, and the phosphorilation of serines 21, 422, 451, 453, 455, 485, 494, 
513 and of threonines 458, 496, 497. Altogether, these events suggest the 
occurrence of a complex post-translational protein regulation. 
 
Figure 3. Structure of the DKC1 gene and its encoded protein.  
In A: structure of the DKC1 gene. Only exons (boxes) are depicted in scale. Empty boxes 
represent 5’ and 3’ Untraslated Regions (UTRs); black boxes represent the CDS. ACA36 and 
ACA56 represent the H/ACA snoRNAs intron-encoded by the DKC1 gene. In B: dyskerin 
protein structure as proposed by Pfam. In blue, low complexity regions corresponding to NLSs 
and Lysine Reach domains (LR); in green, DKLD domain; in red, TruB_N domain; in purple, 
aspartic 125 within the catalytic site; in yellow the PUA domain. 
1.2. GENES BELONGING TO THE Cbf5/DKC1/MFL FAMILY ARE 
INVOLVED IN A WIDE SPECTRUM OF BIOLOGICAL FUNCTIONS 
In all organisms examined so far, from Archaea to 
Eukarya, total loss of function of members of the Cbf5/DKC1/MFL gene 
family lead to early lethality. Members of this family always proved to be 
indispensable for survival, and have been involved in a plethora of disparate 
biological functions. The first member of this family to be identified, the Cbf5 
yeast gene, was firstly described as a gene encoding a centromere binding 
protein (Jiang et al. 1993). Later on, gene inactivation was observed to lead to 
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lethality, and the lethality correlated to failure in the processing and 
pseudouridylation of rRNAs precursors (Zebarjadian et al. 1999). In the same 
year, null mutation in the Drosophila ortholog gene, called mfl, were described 
to cause lethality, and mfl hypomorph mutations were shown to produce 
developmental delay, reduced fertility and inability to properly mature and 
pseudouridylate rRNAs precursors (Giordano et al. 1999). In trypanosomes, 
RNAi (RNA interference) gene silencing of the Cbf5 gene showed that a 
reduction of the Cbf5p protein level led to a sharp slowdown of the growth 
rate, due to a drastic reduction in the synthesis of mature rRNAs. These studies 
also showed a general reduction in pseudouridylation levels of rRNAs, 
snRNAs and SLRNA (Splicing Leader RNA), which is needed for the trans-
splicing mechanism (Barth et al. 2005). Controversial results on the role of 
members of this gene family have been gathered in mammals. In rats, the 
NAP57 protein has been firstly involved in "shuttling" between nucleus and 
cytoplasm (Meier and Blobel 1994). Subsequently, studies in primary cells 
obtained from patients with X-DC and from DKC1 knock-out or mutant mice 
(carrying the same mutations found in human patients) unrevealed that the 
disease is accompanied by a reduction of telomeres length (Mitchell et al. 
1999; Vulliamy et al. 2001). However, in transgenic mice the symptoms 
manifested many generations before the telomeres underwent a real shortening, 
supporting the idea that reduced levels of protein synthesis and 
pseudouridylation played a more important role in the pathogenesis of X-DC. 
When the murine DKC1 gene was replaced by two allelic deletion variants 
(variant DC1, which eliminates exons 12-15, and DC7, which deletes exon 15), 
He and colleagues (2002) observed that females heterozygous for both 
deletions showed a complete embryonic lethality by day 9.5 post conception 
(d.p.c.). At day 7.5 d.p.c., no male embryo was vital, while female embryos 
showed degeneration of extra embryonic tissues. Since in these tissues the 
paternal X chromosome is inactivated, this suggested the occurrence of a 
maternal effect, so far still unexplained at the molecular level. Moreover, 
heterozygous females in which the deletion was of paternal origin had a strong 
tendency to selectively inactivate the mutant chromosome, retaining the wild 
type chromosome active in all cells. Since X chromosome inactivation is a very 
early event in embryonic development, this skewed inactivation pattern is 
likely to result from a “cell competition” mechanism, by which cells that 
inactivated the wild-type chromosome were strongly disadvantaged, and then 
competed-out by cells actively expressing the wild type X chromosome. Mouse 
embryonic cells carrying the two most common DKC1 mutations (A353V and 
G402E) showed a global decrease in the levels of rRNA pseudouridylation and 
a reduced efficiency of pre-rRNA maturation (Ruggero et al. 2003); in 
addition, the A353V mutation also caused a strong destabilization of the 
telomerase RNA component. This feature was reflected by a significant and 
progressive reduction of telomere length with the proceeding of cell divisions 
(Mochizuki et al. 2004). RNAi DKC1 inactivation in human cells confirmed 
either the defect on telomere shortening and the existence of a direct 
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relationship between the amount of functional dyskerin and the degree of 
rRNAs pseudouridylation, further supporting the dual role of this protein in 
these two different but essential processes (Ruggero et al. 2003; Montanaro et 
al. 2006). 
Intriguingly, further studies on mouse cells carrying DKC1 mutations also 
revealed a reduced efficiency of cap-independent mRNA translation (Yoon et 
al. 2006) which takes place at the IRES (Internal Ribosome Entry Site) 
sequences. Although active also in physiological conditions, cap-independent 
translation is known to have a key role in the response to apoptotic stimuli 
(such as  radiations  and in cell cycle phases, when cap-dependent translation 
is reduced (i.e. G0/G1 phases). It is thus possible that rRNA pseudouridylation 
may dramatically affect the ability of the ribosome to recognize IRES 
sequences, a fundamental step for cap-independent translation. Some 
antiapoptotic factors, such as XIAP and Bcl-xL, or proapoptotic, such as p27 
(Kip1), are known to be translated from IRES, and their expression level was 
found to be reduced in DKC1 mutant cells. These findings led to suggest that 
the translational imbalance between antiapoptotic and proapoptotic factors may 
be one of the causes of both the bone marrow failure and the tumor 
susceptibility observed in X-DC patients. 
In conclusion, the data accumulated in mouse, rat and humans indicate that 
dyskerin is certainly involved in at least three basic processes: maintenance of 
telomere integrity; biogenesis and function of the ribosome, and 
pseudouridylation of various cellular RNAs. The involvement of dyskerin in 
maintenance of the telomere ends has been definitively established by recent 
experiments performed by Cohen et al. (2007), which identified by mass 
spectrometry three components participating to the human telomerase active 
complex. In addition to the two expected components, namely the telomere 
reverse transcriptase (TERT) and the telomerase RNA component (TERC), 
dyskerin was found to represent an additional, essential component of the 
complex. Although the association of at least 32 other proteins to the 
telomerase complex is suspected, none of these, except dyskerin, proved to be 
necessary for the catalytic activity (Cohen et al. 2007). 
Intriguingly to note, novel functions have been hypothesized for the snoRNP 
(small nucleolar ribonucleoprotein) complexes in the last years. In fact, several 
reports indicated that H/ACA snoRNAs can act as precursors of miRNAs, a 
feature that appears to be largely widespread in eukaryotes. SnoRNA-derived 
miRNAs have in fact been described so far in Protozoa (Saraiya and Wang 
2008), humans (Ender et al. 2008), mouse, Arabidopsis, yeast, chicken (Taft et 
al. 2009) and Drosophila (Jung et al. 2010). Moreover, the percentage of 
snoRNAs able to be processed into miRNAs has been estimated to range from 
60% in humans and mouse to more than 90% in Arabidopsis. Although the 
snoRNA-miRNA processing mechanism is mostly unclear, it appears to be 
Dicer-1-dependent but Drosha/DCGR8-independent (Ender et al. 2008; Taft et 
al. 2009).  
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Considering that miRNAs play a fundamental role in post-transcriptional gene 
regulation (for a review, see Fabian et al. 2010), it is plausible that 
pseudouridine synthase depletion may widely affect developmental processes 
by inhibiting the snoRNA-derived miRNA regulatory pathway. Indeed, the 
occurrence of a large variety of developmental defects has recently been 
described in Drosophila as consequence of pseudouridine synthase gene 
silencing (Tortoriello et al. 2010). It is thus tempting to suggest that this 
mechanism might possibly account, at least in part, for the plethora of 
manifestations displayed by X-DC. Consistent with this hypothesis, dyskerin 
reduction has been recently shown to impair in an unpredictable way the 
biogenesis of snoRNA-derived miRNAs, allowing a huge spectrum of possible 
effects in conditions in which the expression of DKC1 is perturbed (Alawi and 
Lin 2010). 
Importantly to note, the biological functions attributed to dyskerin, despite their 
apparent diversity, can all essentially be related to its ability to bind and 
stabilize snoRNAs of the H/ACA class. In fact, although the majority of these 
snoRNAs takes part in the pseudouridylation process, a few of them is essential 
for the maturation of pre-rRNA, and thus for the biogenesis of the ribosome. In 
addition, mammalian TERC includes a canonical H/ACA domain, thus sharing 
structural features with H/ACA snoRNAs (see Fig. 5). Considering the crucial 
importance of the snoRNP complexes, next section will be devoted to illustrate 
their structure and function. 
1.3. THE STRUCTURE OF snoRNPS OF THE H/ACA CLASS 
Within the H/ACA snoRNP complexes, dyskerin forms a 
hetero-pentameric complex together with Gar1, Nop10 and Nhp2 proteins and 
one molecule of a snoRNA of the H/ACA class. The complex stabilizes the 
H/ACA snoRNAs, that otherwise would be quickly degraded. 
The assembly of H/ACA snoRNPs is a very early event, since the snoRNAs, 
whose gene are often intronic, are bound by dyskerin before the host intron is 
excised by the splicing mechanism from the primary transcript (Richard et al. 
2006). Intriguingly, all mammal H/ACA class snoRNAs identified till now are 
intron-encoded, even when their host genes do not encode proteins. Those non-
coding host genes are thought to derive from progressive accumulation of 
mutations, with subsequent degeneration of the coding potential of the exonic 
sequences.  
Dyskerin/snoRNA association is irreversible and established during snoRNA 
maturation, whereas association of Nop10, Gar1 and Nhp2 is subsequent and 
temporary, allowing a quick interchange between different snoRNPs (Kittur et 
al. 2006). Although H/ACA snoRNPs share a common proteic “core”, the 
catalytic activity resides on members of the dyskerin family, which catalyze the 
isomerization reaction. The functional specificity of the reaction is instead 
conferred by the particular snoRNA molecule that associates to the complex. 
Each snoRNA acts in fact as guide, selecting the target RNA and the specific 
site to be pseudouridylated by base complementarity. The typical secondary 
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structure of H/ACA snoRNAs is composed 
of two hairpins and two short single 
stranded sequences containing, 
respectively, the H (ANANNA) and ACA 
boxes, with the latter always localized 3 
nucleotides upstream the snoRNA 3’ end. 
Hairpin structures are interrupted by 
recognition loops containing the guide 
sequences; within the region of base pair 
complementarity to the target RNA, the 
first unpaired nucleotide represents the 
uridine that will be modified.  
Figure 4. Assembly of a H/ACA class snoRNP 
(modified from Richard and Kiss 2006). 
In mammals the assembly of H/ACA snoRNPs is co-
transcriptional. The nuclear assembly factor Naf1 
interacts with the C-terminal region of RNA 
polymerase II, aiding the binding of the H/ACA 
snoRNPs core proteins to intronic snoRNA 
sequences. The substitution of Naf1 by Gar1 
determines the release of the mature particle.  
The pseudouridylation pocket is always 
located 14-16 nucleotides upstream of the 
H or the ACA box, depending on which 
pocket is used (see Fig. 6). The most 
common targets of pseudouridylation are 
represented by rRNAs and snRNAs, and 
correct pseudouridylation of these 
molecules seems to be necessary for proper 
functionality and for efficient ribosome 
biogenesis. However, other cellular RNAs 
can be subject to pseudouridylation. In addition a growing number of snoRNAs 
are indicated as “orphan”, with no target RNA identified so far. Intriguingly, 
many “orphans” show a tissue specific expression pattern, as it is the case of 
HBI-36, a snoRNA specifically expressed in the brain, at the level of the 
choroid plexus (Cavaillé et al. 2000). 
Although pseudouridylation represents the most common modification found 
on cellular RNAs, its biological role is still elusive. Pseudouridines are able to 
form hydrogen bridges with bases other than adenine, and its presence can 
influence folding and activity of stable RNAs, like tRNAs, rRNAs and 
snRNAs (Arnez and Steitz 1994; Newby and Greenbaum 2002), and also affect 
their interaction with RNA-binding proteins. 
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Figure 5. Possible functions of H/ACA snoRNPs in mammals (modified from Meier 2005). 
The “core “snoRNP complex, made up of 4 proteins, may bind H/ACA snoRNAs involved in 
different functions. The bound snoRNA determines either the target recognition and the specific 
biological role of the complex. 
Figure 6. Typical 
secondary structure of a 
H/ACA snoRNA molecule 
within the snoRNP 
complex. 
Some information on 
the structure of 
H/ACA snoRNP 
complexes has been 
obtained from X-ray 
crystallography of the Archaeal Pyrococcus furiosus complex (Rashid et al. 
2006), whose structure revealed two distinct domains, a PUA domain facing 
the catalytic domain, and a catalytic domain with high homology to the E. Coli 
TruB protein. The function of the PUA domain seems to be that of anchoring 
in the correct position the RNA helix upstream of the target uridine. Using the 
archaeal Cbf5p structure as template, the same authors proposed, by homology, 
a structural model for the structure of human dyskerin. The model, even if not 
complete because the archaeal protein lacks the dyskerin N-terminal (1-35 aa) 
and C-terminal (359-513 aa) regions, shows that most part of dyskerin 
pathologic mutations, even if falling far apart in the primary sequence, 
converge on the same side of the PUA domain. This finding suggested that 
these mutations may all affect the binding to substrate RNAs, or to a still 
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unidentified partner of the complex. Interesting to note, mutations falling in 
dyskerin regions missing in the archaeal protein would affect the same 
structural region, since those sequences are predicted to wrap the PUA domain.  
Finally, the role of dyskerin in ribosome biogenesis is not limited to 
pseudouridylation. In fact, even if by a still unclear mechanism, the protein is 
involved in rRNA processing under the guide of U17, E2 and E3 snoRNAs (all 
belonging to the H/ACA class). These snoRNAs, which guide the nucleolitic 
processing of rRNAs, are all essential for cell growth. In fact, maturation of 5’ 
end of the 18S rRNA requires the activity, most probably as chaperon, of the 
U17 snoRNA (also called E1), which in human cells is present in two isoforms, 
called U17a and U17b. In turn, the snoRNA E2 is needed for the maturation of 
3’ end of 18S rRNA, whereas the snoRNA E3 drives the maturation of 5’ end 
of the 5.8S rRNA. These essential functions, experimentally verified in 
Xenopus laevis oocytes (Mishra and Elicieri 1997) are evolutionarily conserved 
also in humans. 
Figure 7. Dyskerin structural 
model (Rashid et al. 2006). 
Residues mutated in X-DC 
patients have been 
superimposed to the model 
built on the Pyrococcus Cbf5p 
structure. Mutated residues 
are shown as orange spheres, 
mutations present in single 
families are printed in black, 
those found in more families 
are printed in white. 
 
 
 
 
 
2. AIMS OF THE STUDY 
The DKC1 gene is causative of a congenital disease and 
has been involved in a wide spectrum of essential cellular processes, such as 
ribosome biogenesis, pseudouridylation of cellular RNAs, nucleo-cytoplasmic 
shuttling, maintenance of telomere integrity and snoRNA-derived miRNAs 
production. However, despite its essential role, the gene has been to date very 
poorly characterized at the molecular level. Even if DKC1 is known to have a 
complex coding-non-coding organization and thus is likely to have a complex 
transcriptional pattern, only one 2.6 kb long constitutive transcript coding for 
dyskerin has been so far described and characterized (Heiss et al. 1998).  
Indeed, the majority of efforts have been so far focused on the identification of 
novel mutations and on their functional characterization in model organisms, 
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especially in yeast, Drosophila and mice. On the other hand, considering that 
one of the steps needed for cancer progression is the reactivation of telomerase 
function, additional approaches have been addressed to the comprehension of 
the role played by DKC1 activity in tumorigenesis. In fact, the possibility to 
correlate the levels of DKC1 expression to cancer progression is particularly 
attractive and may possibly furnish an easy and early marker of the process. To 
this regard, I contributed to show that up-regulation of DKC1 gene during 
colon cancer development may represent a more sensitive index than up-
regulation of telomerase activity (Turano et al. 2008). 
In order to increase our knowledge on the molecular mechanisms underlying 
the pathogenesis of X-DC, during my PhD thesis I decided to perform a 
detailed analysis of DKC1 transcriptional activity. I undertook this approach 
because I thought very plausible that the wide spectrum of cellular functions 
performed by the DKC1 gene may, at least in part, rely on the production of 
alternative transcripts. 
Alternative splicing is widely used by eukaryotic genes to generate multiple 
transcripts and proteic isoforms often playing different biological roles, 
sometimes synergic and sometimes antagonistic. Alternative splicing can in 
fact dramatically change the structure of the mature transcripts and their coding 
potential. For many alternative transcripts, even if characterized by a low-level, 
or a transient expression profile, a fundamental role in many cellular processes 
has been established. Taking into account the NMD (Nonsense Mediated 
Decay) mechanism of mRNA surveillance, it has been estimated that 25% of 
alternative exons is fundamental to determine transcript abundance (for a 
review, Stamm et al. 2005). Finally, all the bulk of data present in the recent 
literature indicates that alternative splicing can regulate gene expression in a 
quicker and finer way than the regulation of promoter activity. Indeed, the 
results I have obtained confirmed that DKC1 gene expression is more complex 
than generally accepted, and support the possibility that previously undetected 
alternative transcripts may be responsible, at least in part, for the plethora of 
different manifestations of the X-linked DC. 
3. MATHERIALS AND METHODS  
3.1. COMPUTATIONAL ANALYSIS 
Nucleotide and aminoacid reference sequences were 
those present at the GeneBank (http://www.ncbi.nlm.nih.gov/genbank/). 
Translate and ProtParam analysis tools at the ExPASy web site 
(http://www.expasy.ch/) were used.  
3.2. RNA EXTRACTION 
Total RNAs were extracted from tissues and cultured 
cells by the TRI-reagent (Sigma) following manufacturer’s instructions; RNAs 
were dissolved in a variable amount of 0.1% DEPC treated water. Samples’ 
were quantified by the Nanodrop instrument (Thermo scientific). 
3.3. BASIC CLONING AND MANIPULATION TECHNIQUES  
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Basic cloning techniques, nucleic acids and proteins 
manipulations, SDS-PAGE and wet protein blotting were carried out according 
to Sambrook and Russell (2001).  
3.4. PCR 
Qualitative PCRs were performed using High Fidelity PCR Master Mix 
(Roche) using manufacturer’s instructions and carried out by the MyCycler 
thermal cycler (BioRad). All of the primers were designed by the Primer3 
program (http://frodo.wi.mit.edu/) and have an annealing temperature of circa 
60°C.  
The amplification protocol was: 
94°C 2 minutes for enzyme activation and cDNA denaturation 
10 cycles composed of: 
Denaturation: 94°C 10 seconds 
Annealing: 60°C 70 seconds 
Polymerization: 72°C, the time depended on fragment length, 
considering a 1 kb per minute rate 
20 cycles composed of: 
Denaturation: 94°C 15 seconds 
Annealing: 60°C 30 seconds 
Polymerization: 72°C, the time depended on fragment length, 
considering a 1 kb per minute rate and an increase of 5 seconds per 
cycle 
Then a single final extension: 72°C 7 minutes 
The reaction products were verified on agarose gel stained by ethidium 
bromide. 
Oligonucleotides used for cloning the isoforms are: 
ISOFORM FORWARD PRIMER REVERSE PRIMER 
Commons AGGGTAACATGGCGGATG TCAACAAGAAAACCCAACAGG 
Isoform 3 TGTGTTTGACTTCACTTTGACTAAA GGTAAGGCCAGCACCATTTA 
Isoform 4 GGAGGGAAGGACTGGCTAGA CCAGCAGACAAAACATAGAAGG 
Isoform 5 ATCTCCTGACGTCGTGATCC GTAGAGACGGGGTTTCACCA 
Isoform 6 TGGGCTAAGGGAGATGATTG CTCCCAAAGTGCTGGGATTA 
Isoform 7 ATGGGAAGGTAGAGCCCACT CTGAAACATCCTGCCCTCAC 
3.5. qRT-PCR 
The Real time PCR samples preparation, amplification 
and analysis were performed as described elsewhere (Turano et al. 2008). The 
amounts of DKC1 gene transcripts in different samples were normalized 
respect to housekeeping gene. The housekeeping genes used were: GAPD for 
tissues comparison, POLR2A for Caco-2 and SK-N-BE(2) differentiation and 
GSS for NDM inhibition, the sequences of the primers used are: 
GENE FORWARD PRIMER REVERSE PRIMER 
POLR2A TGCTCCGTATTCGCATCATG TCCATCTTGTCCACCACCTCTT 
GAPD ACAGAGTGAGCCCTTCTTCAA GGAGGCTGCATCATCGTACT 
GSS GGACTGGCCCTGGGAATT CCTTCTCTTGAGCAATCAGTAGCA 
The sequences of primers used for DKC1 transcripts amplification are: 
ISOFORM FORWARD PRIMER REVERSE PRIMER 
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Isoform 1 CTCGGAAGTGGGGTTTAGGT ACCACTTCAGCAACCACCTC 
Isoform 3 GGCGGATGCGGAAGTAAT TTTTAGTCAAAGTGAAGTCAAACACA 
Isoform 4 TTTTCCTGCTGTGCAAAAT GCTGGAATAAGGCACCTGTC 
Isoform 5 GGCTGCACAATGCTATTGAA CATACCCACTCACAGGCCTAA 
Isoform 6 CTCCCAGCCTACAAAAATGC CACATCATGCATTGTCACCA 
Isoform 7 CTCGGAAGTGGGGTTTAGGT CTGAAACATCCTGCCCTCAC 
The sequences of primers used as treatments controls are: 
GENE FORWARD PRIMER REVERSE PRIMER 
rpL3 ATGAATGCAAGAGGCGTTTC CTAAGGAGCCTTTTCCACCA 
S100G CCAGACCAGTTGTCAAAGGA TCCATCTCCATTCTTGTCCA 
RET CCACGGTGGCCGTGAA CTGACAGCAGGTCTCGAAGCT 
All oligo pairs produce an amplicon of circa 150 bp. 
All the primer pairs employed are separated by at least one intron so to prevent 
the amplification of contaminating genomic DNA. 
3.6. DNA EXTRACTION FROM AGAROSE GEL 
PCR products were loaded on agarose gel and run for 45 
minutes at 100V to ensure fragments separation. The bands of interest were cut 
and DNA fragments eluted by the Nucleospin Extract II kit (Macherey-Nagel) 
following manufacturer’s instructions. 
3.7. CLONING IN THE pGEM T-Easy VECTOR 
The plasmid used for sequencing reactions is the pGEM 
T-Easy vector (Promega), ligation and transformation were performed 
following manufacturer’s instructions. 
3.8. CLONING IN THE p3XFLAG-CMV-10 VECTOR 
The fragments corresponding to Isoform 1 and 7 CDS 
were amplified using 3 different primers. These primers contain, upstream to 
the sequence complementary to transcripts, sequences target of specific 
restriction enzymes for directional cloning in the expression vector. The 
primers are: 
5’CCCAAGCTTGGTAACATGGCGGATGCG3’ located in exon 1, 
contains the AUG, the HindIII site is underlined, is common to both 
fragments 
5’CCGGAATTCTCCAGCTTCAAGTGGCC3’ located in exon 15, the 
EcoRI site is underlined, defines the stop codon of Isoform 1 
5’CCGGAATTCACCCCGGCTCTGAAACATC3’ located in intron 
12, the EcoRI site is underlined, defines the stop codon of Isoform 7 
The PCR products were first purified, then subject to double enzymatic 
restriction. Fragments were again purified and ligated into the p3XFLAG-
CMV-10 plasmid using a 6:1 (insert/plasmid) ratio.  
3.9. MIDI PLASMID DNA EXTRACTION FOR CELL 
TRANSFECTION 
To obtain endotoxins free plasmid positive clones were 
extracted by the GeneElute
TM
 HP Plasmid Midiprep kit (Sigma) following 
manufacturer’s instruction, the plasmids were stored at +4°C. 
3.10. CELL COLTURE AND TREATMENT 
3.10.1. Cell culture 
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The cell lines used were: MCF-7 breast adenocarcinoma, 
HeLa cervix adenocarcinoma, ZR-75.1 breast ductal carcinoma, Caco-2 
colorectal adenocarcinoma and SK-N-BE(2) neuroblastoma. Cell lines were 
grown in DMEM (Dulbecco’s Modified Eagles Medium) supplemented with 
FBS 10% (MCF-7, HeLa and ZR-75-1), 15% (SK-N-BE(2)) or 20% (Caco-2); 
2 mM L-glutamine, penicillin 100 U/ml and streptomycin 100 µg/ml at 37°C 
5% CO2 in a humidified chamber, all chemicals were from Invitrogen.  
3.10.2. Cell treatments and differentiation 
To evaluate NMD regulation, protein translation of 
Caco-2 cells was blocked by cycloheximide 100 µg/ml for 2 hours. Caco-2 
cells were induced to differentiate as described by Pinto et al. (1983) and 
Pignata et al. (1994). To induce the differentiation of SK-N-BE(2), cells were 
treated as described elsewhere (Tahira et al. 1991; D’Alessio et al. 1995; Corvi 
et al. 1997). Growth curve were calculated counting cells by a Burker chamber 
and seeded 5x10
5
 cells per 5 cm culture dish. They were counted for successive 
4 days. The experiment was repeated 3 times. Cell-matrix adhesion was 
evaluated as described by Wang and colleagues (2010). For X-ray surviving 
assay cells were seeded on plastic culture dishes and when confluence was at 
50% cells were subjected to increasing doses of X-ray: 0, 2, 4, and 6 Gy at a 
rate of 1 Gy/minute. Then cells were detached by trypsin, counted and seeded 
at serial dilution to evaluate cloning potential. After 8 days clone density was 
near the ideal 1 clone every 50-200 cm
2
 of culture dish so cells were fixed with 
10% methanol 10% acetic acid for 10 min at room temperature, washed with 
PBS and stained with Crystal Violet solution. The experiment was repeated 
trice. 
3.10.3. Cell transfection 
For transient and stable transfection HeLa cells and 
Lipofectamine reagent (Invitrogen) according to manufacturer’s instructions 
were used. For transient transfection 10
6
 cells were seeded into a 10 cm culture 
dish containing 1 microscope slide coverslip for fluorescent 
immunolocalization and transfected by 8 µg of each plasmid. For stable 
transfection 2x10
5
 cells were seeded into 5 cm culture dishes and transfected 
by 1 µg of each plasmid, stably transfected clones were selected by G418. 
3.11. PROTEIN EXTRACTION AND QUANTIFICATION 
For protein extraction, cells were washed twice with ice 
cold PBS, detached from dish by a cell scraper and harvested in 4 ml of PBS. 
Cells then were pelleted by centrifugation for 5 minutes 1400xg at 4°C. The 
PBS was eliminated and cells resuspended by gentle vortex in 100 µl of RIPA 
lysis buffer. After 30 minutes of incubation in ice, the cell lysates were 
transferred in micro centrifuge tubes and centrifuged for 15 minutes 14000 rpm 
at 4°C to eliminate insoluble material. The supernatants were transferred in 
new tubes and stored at -80°C. Protein concentration of extracts was 
determined by the BioRad reagent following manufacturer’s instructions. 
3.12. WESTERN BLOT ANALYSIS 
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The membranes produced by proteins blotting were 
washed trice for 5 minutes with TBS-t-m (TBS-t containing 5% non fat dried 
milk). Then membranes were incubated with anti-FLAG antibody (Sigma) 
diluted 1:5000 in TBS-t-m for 2 hours at RT. The membranes were washed 
trice for 5 minutes with TBS-t-; then they were exposed to anti-mouse antibody 
(SantaCruz) conjugated with horseradish peroxidase diluted 1:5000 in TBS-t-
m. Membranes were washed again in same conditions and exposed to ECL-
Plus (GE Healthcare) for 5 minutes. The excess of ECL-Plus was eliminated 
and chemioluminescence was visualized exposing the membrane into the 
ChemiDoc (BioRad) and images were saved on a PC. 
3.13. FLUORESCENT IMMUNOLOCALIZATION 
Fluorescent immunolocalization was performed by a 
secondary antibody conjugated to TexasRed. Cells attached to coverslips were 
washed for 5 minutes with PBS (thereafter simply washed), then fixed for 10 
minutes at RT with 3.7% formaldehyde in PBS. Samples were washed then 
cells were permeabilized by 0.5% Triton X-100 in PBS for 15 minutes at RT 
then washed. Primary anti-FLAG antibody diluted 1:250 in PBS with 0,02% 
Tween was added and incubated for 1 hour. From this point the steps were 
performed in dark; samples were washed and secondary anti-mouse antibody 
diluted 1:250 in PBS with 0,02% Tween was added and incubated 1 hour. 
Coverslips were washed and exposed to DAPI diluted 1:5000 in PBS for 5 
minutes to counterstain nuclei after a final wash slides were mounted by PBS 
with 50% glycerol and coverslip borders sealed with nail paint 
3.14. HISTOLOGICAL STAININGS AND IMAGE ANALYSIS 
Cell blocks were prepared harvesting cells in Versene 
solution (PBS plus 53 mM EDTA). Cells were centrifuged for 6 minutes at 
4000rpm then fixed by 10% formalin in ethanol for 45 minutes; alternatively 
cells were grown on coverslips and directly fixed by 3.7% formalin in PBS and 
stained. Fixation of cells grown on coverslips was performed like in 
immunofluorescence. Standard haematoxylin eosin, Papanicolaou, silver 
nitrate active NORs stainings were performed according to Bandcroft and 
Gamble (2007).  
Deparaffinization and rehydratation: 
Xylene 10 minutes 
Ethanol 100% 10 minutes 
Ethanol 80% 10 minutes 
Ethanol 70% 10 minutes 
Ethanol 50% 10 minutes 
Distilled water 10 minutes 
Final dehydratation and clearing were performed with same times and 
concentrations but in opposite order. Haematoxylin eosin stained sections were 
photographed under light transmission microscope, nuclear and cytoplasmic 
areas were measured on acquired images by the ImageJ software 
(http://rsbweb.nih.gov/ij/); mean, standard deviation and one tailed Student’s t-
test were calculated by Excel software (office.microsoft.com). 
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4. RESULTS AND DISCUSSION 
4.1. COMPUTATIONAL ANALYSIS 
Starting from DKC1 (GeneID: 1736) known sequences 
(NC_000023 for gene, NM_001363 for the 2.6 kb ubiquitary Isoform 1 and 
NM_001142463 for the predicted Isoform 2), I searched the dbEST database 
by the BLAST algorithm (Basic Logic Alignment Search Tool), using as 
queries the sequences of all introns of the gene. The GenBank dbEST 
represents a powerful tool for analysis of gene expression and the search of 
alternative transcripts. My search resulted in the identification of 5 DKC1 ESTs 
(Expressed Sequence Tags) with accession numbers: DB121984, CN312112, 
CB987783, DR159215, CN312110, here referred as Isoform 3, 4, 5, 6 and 7 
respectively. Alignment of each EST on the genomic sequence of the DKC1 
gene is reported in Fig. 8. As shown in the figure, all the identified ESTs were 
characterized by partial or complete retention different DKC1 gene introns. 
 
Figure 8. Structure of the DKC1 gene and DKC1-derived ESTs annotated on the dbEST 
database and characterized by intron retention. 
On the top, structure of the DKC1 2.6 kb canonical transcript (Isoform 1). Only exons (boxes) 
are depicted in scale. Empty boxes represent 5’ and 3’ UTRs, black boxes represent CDS, 
ACA36 and ACA56 represent the H/ACA snoRNAs intron-encoded by the gene. Below, the 
structures of the five ESTs identified in this study. 
4.2. IDENTIFICATION OF DKC1 ALTERNATIVE TRANSCRIPTS 
Starting from the structure of the five ESTs identified, I 
attempted to confirm their expression and define the complete structure of the 
putative transcripts from which they should derive. With this aim, total RNA 
was extracted from two breast cancer cell lines (MCF-7 and ZR-75.1) and from 
five normal tissues (breast, colon, uterus, placenta and lymphocytes) and RT-
PCR experiments focused to specifically detect the expression of EST-related 
transcripts were performed. The results obtained confirmed the effective 
accumulation of the predicted transcripts in either the examined cell lines (not 
shown) and the tested tissues (see Fig. 9). These analyses also revealed that the 
levels of expression of these transcripts could be differentially modulated in the 
diverse tissues. In fact, while Isoform 1 was found expressed at similar levels 
in all tissues, Isoform 4 was undetectable in the uterus, while Isoform 6 in 
breast. In contrast, Isoform 5 proved to be up-regulated in uterus, while 
Isoform 7 was up-regulated in lymphocytes and placenta (Fig. 9). Even if these 
preliminary data were only semi-quantitative, they confirmed the actual 
expression of previously undetected DKC1 alternative transcripts. However, 
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neither in normal tissues or cell lines we were able to amplify any fragment 
related to Isoform 2 expression. It seems possible that this dbEST-annotated 
isoform might actually derive from an artifact, or alternatively, from a 
transcript specifically expressed in a tissue not examined in our experiments. I 
cannot in fact exclude that expression of the Isoform 2-related transcript can be 
restricted to the embryonal carcinoma cell line, from which the only EST 
representative of this hypothetical transcript, BG258928, has been annotated. 
 
Figure 9. Expression profiles of 
alternative DKC1 transcripts 
determined by RT-PCR experiments.  
The constitutive and ubiquitous Isoform 1 
is expressed at a similar level in all the 
tested tissues, whereas the expression of 
newly identified isoforms appears to be 
differently modulated in the diverse cell 
types. Expression of the ubiquitously and 
constitutively expressed GAPD 
(Glyceraldehyde-3-phosphate 
dehydrogenase) gene is shown for 
internal normalization. 
In order to define the complete 
structure of the newly identified 
transcripts, I performed additional 
RT-PCR experiments focused to 
clone full length cDNAs using as 
template RNA extracted from the MCF-7 cell line. The strategy followed in 
these experiments (depicted in Fig. 10) was aimed to amplify the regions 
upstream and downstream each EST annotated sequence, and made use of 
primers derived from the first and the last DKC1 exons (exon 1 and exon 15), 
coupled with isoform-specific intronic primers. 
PCR products were loaded on agarose gel to check the correct size and then 
cloned into the pGEM T-Easy vector for sequencing reactions. Positive clones 
were sent to the external company Primm (Primm, Milan Italy) for nucleotide 
sequencing.  
 
Figure 10. RT-PCR strategy followed for the amplification of the novel DKC1 transcripts. 
Primers P1 and P4 were common to all the isoforms and were located outside of the CDS 
contained within the canonical Isoform 1, whereas primers P2 and P3 were isoform-specific and 
derived from the specifically retained intron. 
4.3. CODING POTENTIAL OF THE NEWLY IDENTIFIED DKC1 
TRANSCRIPTS 
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Nucleotide sequence analysis revealed that DKC1 
alternative transcripts differed from Isoform 1 only for the retention of specific 
introns. When the coding potential of the new isoforms was evaluated by the 
online program “Translate” of the ExPASy web site, a software that enables 
the simultaneous search of CDS in all the three possible frames, I observed that 
the CDS starting at the dyskerin first AUG codon was maintained in all of 
them. However, with the exception of Isoform 7, these CDS were significantly 
shorter than that of canonical dyskerin, because of the occurrence of premature 
stop codons (PTCs) at different points. As consequence, the putatively encoded 
proteins would miss one or more carboxy-terminal dyskerin functional 
domains (see Fig. 11). Strikingly, these upstream CDSs were followed by 
significantly longer, and in frame, CDSs which, conversely, would miss N-
terminal or internal dyskerin functional domains. 
 
Figure 11. Complete structure and coding potential of the new DKC1 transcripts.  
Nucleotide sequencing of the novel isoforms demonstrated that dyskerin CDS (black boxes) is 
precociously interrupted in most of them, thus being able to direct the synthesis of truncated 
proteins missing one or more C-terminal functional domains. Note presence of longer, 
downstream CDSs (red boxes) within isoforms 3,4,5,and 6.  
The coding properties of novel DKC1 isoforms are described here in more 
detail. Isoform 3, that is characterized by retention of the whole intron 2, 
includes a very short upstream CDS that is able to encode a peptide, only 28 aa 
long, of unpredictable function.  
Isoform 4 is instead characterized by retention of the whole intron 5, and its 
upstream CDS potentially encodes a protein of 159 aa (18 kDa) which would 
include the N-terminal NLS, the DKLD domain and part of the TruB_N 
domain, comprising the catalytic aspartic residue. This short protein would lack 
the PUA RNA binding domain, leading to exclude that it can act as catalytic 
pseudouridine synthase. 
Isoform 5 upstream CDS retains intron 7, and would encode a protein of 219 aa 
(27.7 kDa) which includes the N-terminal NLS, the DKLD and most of the 
TruB_N domain, including the catalytic aspartic residue. However, also this 
truncated protein lacks the PUA RNA binding domain, and thus should be 
unable to act as catalytic pseudouridine synthase.  
Isoform 6 upstream CDS is characterized by partial retention of intron 8 and 
would encode a protein of 313 aa (35.1 kDa) which includes the N-terminal 
NLS, the complete DKLD and TruB_N domains but still lacks the PUA 
domain, which is essential for RNA binding. Worth noting, this isoform 
derives from the usage of an internal donor splice site located downstream the 
  
 24 
intron-encoded snoRNA ACA36, coupled with the canonical downstream 
acceptor splice site and polypyrimidine tract. As consequence of this splicing 
pattern, the snoRNA ACA36 is exonized, and this event might possibly 
antagonize its biogenesis through the splicing-dependent mechanism.  
As mentioned above, each of the above listed isoforms present an additional 
downstream CDS, starting at an internal in frame AUG codon. These CDSs are 
significantly longer than the upstream, and all potentially encode variant 
proteins containing the C-terminal dyskerin moiety. For example, for both 
isoforms 3 and 4, a downstream CDS starting at an AUG codon located in exon 
7 would encode a protein of 311 aa with a weight of 34.8 kDa (kilo Dalton), 
which is predicted to contain the C-terminal region of the TruB_N domain, 
devoid of the catalytic aspartic, the PUA domain and the C-terminal NLS.  
Similarly, Isoform 5 presents a downstream CDS starting at an AUG codon 
located in exon 8. This CDS would encode a protein of 272 aa (30.4 kDa) 
composed of the C-terminal moiety of the TruB_N domain, which included the 
catalytic aspartic, the PUA domain and the C-terminal NLS.  
Finally, within Isoform 6 an internal AUG located at exon 9 marks a CDS able 
to produce a protein of 255 aa (28.4 kDa), which includes only the PUA 
domain and the C-terminal NLS.  
Although synthesis of these putative proteins would depend on an internal 
IRES, whose activity remains to be demonstrated, it is interesting to note that 
these products are all predicted to retain the ability to bind RNA, but would 
lack the catalytic pseudouridine synthase activity. This feature is compatible 
with the possibility that, if produced, they might act as dyskerin dominant-
negative regulators. Alternatively, it is plausible to hypothesize that they can 
simply act as snoRNA-chaperones, with no active role in the pseudouridylation 
process. 
Noticeably, Isoform 7 is the only transcript that, similarly to Isoform1, contains 
a single, long CDS. This isoform differs from Isoform 1 only for retention of 
intron 12, an event that would lead to the exonization of the snoRNA ACA56. 
As mentioned above, this event might antagonize the snoRNA biogenesis 
through the splicing-dependent mechanism and might have functional 
relevance, since this snoRNA is known to act as miRNA precursor (Ender et al. 
2008). Moreover, Isoform 7 particularly attracted my interest because it would 
encode a 420 aa protein (47.6 kDa) that includes all the dyskerin functional 
domains, with the exception of the C-terminal NLS. This putative protein was 
likely to keep the pseudouridine synthase catalytic activity, although its nuclear 
localization could possibly be affected by the absence of the C-terminal NLS. 
Expression of this protein might be of functional relevance also in the light that 
Pearson et al. (2008) reported a case of a HHS male child patient carrying a 
DKC1 mutation at position +1 of intron 12. This mutation would lead to intron 
12 retention, exactly as observed for Isoform 7, and was not embryonic lethal, 
although the child patient died at age 2 years. Altogether, these observation 
made Isoform 7 very attractive for further studies. 
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To get a more complete information about all the DKC1 putatively encoded 
variant proteins, I also analyzed their sequences with the “ProtParam tool” at 
the ExPASy web site for a detailed prediction of their weight, isoelectric point 
(pI) and instability index (II). This latter parameter, based on the composition 
of the first dipeptide of the protein, was calculated on all the 400 possible 
dipeptides by Guruprasad and colleagues (1990). Proteins with II values of 40, 
or below, are predicted to be stable, whereas those with higher values are 
presumably unstable.  
Table 2: Predicted parameters of DKC1 putative alternative isoforms. 
Isoform 
Frame 1 
aa 
kDa pI II S/U 
Frame 2 
Aa 
kDa pI II S/U 
1 513*
 
57.5 9.46 44.77 U N/A N/A N/A N/A N/A 
2 508
#
 56.9 9.50 45.03 U N/A N/A N/A N/A N/A 
3 28 3.2 9.22 64.84 U 311 34.8 9.25 45.00 U 
4 159 18.0 9.40 42.36 U 311 34.8 9.25 45.00 U 
5 219 27.7 9.55 49.28 U 272 30.4 9.39 44.66 U 
6 313 35.1 9.51 46.24 U 255 28.4 9.35 39.31 S 
7 419
#
 47.5 9.40 44.01 U N/A N/A N/A N/A N/A 
Frame 1 aa: always starting from the Isoform 1 canonical AUG; Frame 2 aa: starting from a 
downstream AUG, located in exon 7 for Isoform 3 and 4, in exon 8 for Isoform 5 and in exon 9 
for Isoform 6; aa: length in aminoacids, kDa: weight in kilo Dalton, pI: isoelectric point, II: 
instability index score, S/U: result of II, S: stable, U: unstable. * the analysis was performed on 
the mature form, missing of the initial methionine; # it was supposed an elimination of initial 
methionine similar to Isoform 1; N/A not allowed. 
The properties of all putatively encoded proteins are listed in Table 2. DKC1 
variant proteins are all predicted to have a quite basic pI (ranging from 9.22 to 
9.55), most probably for the high content of lysines and arginines at the 
terminal NLSs. Intriguingly, on the basis of their II, all are predicted to be quite 
unstable, with the exception of the product of Isoform 6 downstream CDS. 
Strikingly, also the canonical dyskerin (Isoform 1) is predicted to be quite 
unstable. Even if it is not possible to judge the effect of the acetylation of 
alanine 2 on the predicted II, this observation unravels that this fundamental 
protein might have a fast turnover, so far unnoticed. Finally, it is worth noting 
that most of the DKC1 variant isoforms are predicted to differ from canonical 
dyskerin also for several post–translational modifications, a feature that may 
also be of wide functional relevance. 
4.4. QUANTITATIVE EVALUATION OF DKC1 ISOFORM 
EXPRESSION UNDER NMD INHIBITION 
The production of a translationally competent mRNA is 
the result of the combination of transcription, maturation, nuclear export and 
maturation of the messenger ribonucleoparticle. In higher eukaryotes, the 
quality control of mRNAs is a fundamental process. In fact, the elimination of 
anomalous transcripts that contain PTCs, and are thus able to drive the 
synthesis of truncated proteins with detrimental effects (like, for example, 
negative dominance), is of primary importance. One of the mechanisms that 
performs this control is named NMD (for a review Maquat 2004; Amrani et al. 
2006). PTC-containing transcripts may be generated in different ways: from 
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transcription of a mutated gene, from errors during transcription, from incorrect 
splicing that generates frame-shifting, from missing or incomplete intron 
elimination, from transcription of a pseudogene, etc. However, production of 
PTC-containing alternative transcripts may also represent an important 
physiological mechanism of self-regulation of gene expression, aimed at down-
regulate the level of the encoded protein (Lewis et al. 2003). Since all the 
newly identified DKC1 transcripts were characterized by presence of PTCs, I 
wished to check whether their expression could be down-regulated by the 
NMD surveillance mechanism, as expected for physiological aberrant 
transcripts. Position of PTCs within isoforms 3, 4, 5, 6 and 7 respect the 
downstream exon-exon junction is summarized in Table 3. 
Table 3. Position of PTCs within DKC1 alternative isoforms. 
Isoform nt
*
 EJ 
3 542 3-4 
4 629 6-7 
5 1030 8-9 
6 199 8-9
§
 
7 564 13-14 
* nucleotides upstream of exons junction (EJ); § referred to the internal splice site of intron 8. 
To be activated, NMD needs ongoing protein synthesis, so the simplest way to 
highlight the occurrence of this regulatory mechanism is to inhibit protein 
synthesis by culturing cells in a medium containing the appropriated 
antibiotics. I then treated Caco-2 cells with cycloheximide and analyzed by 
reverse transcription quantitative Real time PCR (qRT-PCR) the total RNA 
extracted from both treated and untreated control cells after a set-up phase, 
necessary to check the efficiency of the primer pairs to be used in transcript 
quantification. In qRT-PCR experiments, the expression of the glutathione 
synthetase gene was used to normalize the RNA amount among different 
samples, while the expression of an alternatively spliced form of the RPL3 
gene, that is known to be under the control of NMD (Cuccurese et al. 2005), 
was employed as positive control. As expected, under NMD inhibition the 
expression of Isoform 1 was unaffected. Surprisingly, the expression of 
alternative DKC1 transcripts, all containing PTCs, was similarly unaffected 
(Fig. 12). This finding suggests the possibility that these transcripts may have 
functional significance, and poses intriguing questions about their possible 
functions and on the molecular mechanisms by which they escape the NMD 
surveillance. 
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Figure 12. Expression of different isoforms produced by the DKC1 gene in Caco-2 cells 
treated with cycloheximide. 
The levels of all isoforms were unaffected by NMD inhibition. CHX: cycloheximide-treated cells; 
CTRL: control untreated cells. The expression of the rpl3-a alternative transcript is shown as 
positive control of NMD inhibition. 
4.5 EXPRESSION OF DKC1 ISOFORMS DURING IN-VITRO CELL 
DIFFERENTIATION 
Since in previous semi-quantitative RT-PCR experiments 
the level of expression of the various DKC1 transcripts appeared to be 
differentially modulated in the diverse tissues, I checked their expression 
during in-vitro differentiation of cultured cells. The expression levels of the 
various isoforms was then followed during differentiation of two cell lines by 
qRT-PCR. The expression of DKC1 isoforms was firstly checked in Caco-2, a 
colon carcinoma cell line that differentiate spontaneously during cell culture, 
and subsequently in SK-N-BE(2), a neuroblastoma cell line whose 
differentiation is induced by trans retinoic acid. Caco-2 cells were grown as 
described (Pinto et al. 1983; Pignata et al. 1994) and cellular RNA extracted 
and analyzed by qRT-PCRs on days 4 (used as reference point), 6, 8, 11 and 15 
of cell growth. In these experiments, the level of S100G mRNA, a gene 
encoding a calcium binding protein whose expression represents a 
differentiation marker of Caco-2 cells (Wang et al. 2004), was measured as 
positive control. As shown in Fig. 13, S100G expression increased significantly 
from day 6 onwards, peaking at day 11. In contrast, expression of DKC1 
isoforms 1, 4 and 7 slightly, but constantly decreased along differentiation, 
starting from day 6 onwards. Expression of isoforms 3, 5, 6 was reduced at a 
lesser extent, possibly suggesting a vaguely distinct conduct. However, it can 
reasonably be concluded that differentiation of Caco-2 cells is accompanied by 
only a modest reduction of all DKC1 transcripts. 
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Figure13. Expression of DKC1 transcripts during Caco-2 cells differentiation. 
Expression of the S100G gene was followed as differentiation marker. D: days. 
The expression of DKC1 isoforms was then followed during differentiation of 
the human neuroblastoma SK-N-BE(2) cell line (Tahira et al. 1991; D’Alessio 
et al. 1995; Corvi et al. 1997). Total RNA was extracted at 0, 2, 4 and 6 days 
after trans retinoic acid induction, and the level of RET mRNA followed as 
positive control of cell differentiation (Tahira et al. 1991). As shown in Fig. 14, 
RET expression was strongly induced from day 2 onwards. The accumulation 
of DKC1 transcripts appear instead to be differently regulated along cell 
differentiation. In fact, Isoform 1 expression seemed essentially unaffected, 
while Isoform 3 and 7 were progressively down-regulated. In contrast, 
Isoforms 6 and 4 were up-regulated, with Isoform 4 particularly and 
significantly induced. Finally, Isoform 5 showed a very weak expression in this 
cell line, so that its expression was not significantly detected at all time point. 
These results clearly indicated that expression of DKC1 isoforms can be 
complex and finely tuned, and can be autonomously and differentially 
regulated during in-vitro cell differentiation. This finding suggests the different 
isoforms may exhibit different temporal and tissue expression profile also in-
vivo. Thus, it would be interesting to analyze a wider panel of differentiating 
cells, in order to get a more complete picture of the expression profile of each 
isoform and acquire more information on their specific biological roles. 
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Figure 14. Expression of DKC1 transcripts during SK-N-BE(2) cell differentiation.  
The expression of the RET gene was followed as differentiation marker .N.I: Not induced; D: 
days.  
4.6 OVEREXPRESSION OF ISOFORM 1 AND 7 IN TRANSIENTLY 
TRANSFECTED HeLa CELLS 
As mentioned above, my attention was mainly attracted 
by Isoform 7, on the basis of its coding properties and of the possibility that it 
may represent the main transcript expressed in a male child patient described in 
a recent case report (Pearson et al. 2008). To gain further information on its 
biological roles, I attempted to overexpress this isoform in HeLa cells. In 
parallel, I attempted to overexpress the canonical dyskerin (Isoform 1) as side-
control. The CDS of these two isoform was then amplified by the use of 
specific primers and then cloned in frame into the mammalian expression 
vector p3XFlag-CMV-10. After suitable controls, each plasmid was used in 
transfection experiments, together with the p3XFlag-CMV-10 empty vector 
used as mock-control (here referred as 3XF-mock). Thereafter, I will refer to 
the p3XFlag-CMV-10 plasmid expressing Isoform 1 as 3XF-Iso1, and to the 
p3XFlag-CMV-10 plasmid expressing Isoform 7 as 3XF-Iso7. After 
transfection, clones transiently expressing 3XF-Iso1, 3XF-Iso7 and 3XF-mock 
were isolated and expression of isoforms 1 and 7 checked by western blot 
analysis. Recombinant proteins with sizes compatible with that expected (60 
kDa for Isoform 1 and 50 kDa for Isoform 7) were efficiently revealed by the 
anti-Flag antibody (Fig. 15) in western analysis. The specific bands showed 
only a slight increase in the apparent weight, as usually observed also for the 
endogenous dyskerin. Once verified the effective expression of the DKC1 
isoforms, the transfected cells were grown on cover slips to visualize the 
intracellular protein localization by fluorescent immunolocalization.  
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Figure 15. Western blot analysis of transiently transfected cells 
overexpressing isoforms 1 and 7.  
The anti-Flag antibody was used for immunodetection of the fused proteins. 
Lane 1: 3XF-Iso1, Lane 2: 3XF-Iso7, Lane 3: Page ruler protein marker 
(Fermentas). The red arrow indicates position of the 70 kDa band of the 
marker, the black arrow that of the 55 kDa band. 
As expected, cells overexpressing the Isoform 1-FLAG fused 
protein showed the fluorescent signal specifically localized 
into the nucleoli (Fig. 16). This observation testified that 
addition of the FLAG peptide does not cause per se any 
mislocalization of the fused protein. In contrast, localization of 
the Isoform 7-FLAG protein was found totally cytoplasmic, with no nuclear 
signal detected (Fig. 16).This finding indicates that presence of the amino-
terminal NLS is not sufficient to determine a nuclear localization of the 
protein, in good agreement with data reported by Heiss et al (1999). These 
authors prepared several deletion constructs encoding truncated forms of 
dyskerin and then examined their subcellular localization. Consistent with our 
data, a truncated protein lacking the C-terminal NLS (named dys446Δ514), 
even if 25 aa longer than Isoform 7, similarly showed a markedly reduced 
nuclear accumulation.  
 
Figure 16. Fluorescent immunolocalization of transiently transfected HeLa cells. 
In A, immunolocalization of Isoform 1-FLAG fused protein, obtained with the anti-FLAG 
antibody. The signal localizes specifically in the nucleoli. In B, nuclei are counterstained with 
DAPI. C, merge of A and B. D: immunolocalization of Isoform 7-FLAG fused protein, obtained 
with the anti-FLAG antibody. The signal is totally absent from the nuclei and totally restricted to 
cytoplasm. In E, nuclei are counterstained with DAPI. F: merge of D and E. 
Given that dyskerin is an essential component of two important nuclear 
complexes, such as that of the H/ACA snoRNPs and active telomerase, the 
potential role played by this cytoplasmic variant protein is quite puzzling. 
Nonetheless, previous reports raised the possibility that dyskerin might play 
some unexplained roles also in the cytoplasm. For example, in rat cells the 
dyskerin homolog protein, named Nap57p, has been reported to be involved in 
nucleo-cytoplasmic shuttling (Meier and Blobel 1994). More recently, 
proteomics strategies identified human dyskerin as a RPS19 interacting protein 
in cytoplasmic extracts (Orrù et al. 2007). Finally, a role for dyskerin in 
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directing cap-independent translation starting at the IRES sequenced has been 
assessed, but so far no clearly explained, in both mouse and human cells (Yoon 
et al. 2006, Bellodi et al. 2010, Montanaro et al. 2010) Although further 
experiments are required to establish whether Isoform7 may be directly 
involved in some of the above mentioned processes, it is relevant to note that 
this variant protein still keeps the PUA domain, which is essential to bind and 
stabilize the H/ACA snoRNAs, where the majority of the mutations causing 
dyskeratosis congenita cluster. Presence of the PUA domain is compatible with 
the hypothesis that this protein may have a role in cap-independent translation, 
or act as snoRNA chaperone, possibly transporting the snoRNA-derived 
miRNAs from the nucleus to the cytoplasm. According to this latter 
hypothesis, mammalian pseudouridine synthases might, as recently described 
in Drosophila, be involved in crucial developmental processes, such as Notch 
signaling, cell adhesion and cell competition (Tortoriello et al. 2010), thus 
interlacing cell growth and development. 
4.7 ISOLATION AND CHARACTERIZATION OF STABLY 
TRANSFORMED CLONES OVER-EXPRESSING DKC1 ISOFOM 7 
In order to carefully evaluate the effects caused by 
Isoform 7 overexpression, I then isolated and characterized stably transformed 
HeLa clones. In parallel, I also attempted to isolate stably transformed clones 
overexpressing Isoform 1. However, none of the selected 3XF-Iso1 clones 
showed expression of the fused protein. Only in two independently isolated 
clones (number 8 and 16, see Fig. 17), the anti-FLAG antibody detected a band 
of the apparent weight of about 100 kDa. This band is heavier than expected 
and possibly derives from an internal rearrangement of the expression construct 
which eliminated, at least in part, Isoform 1 sequences. In fact, I could not be 
able to amplify from the genomic DNA of these two clones Isoform 1-FLAG 
fused sequences. The failure to isolate clones overexpressing dyskerin has been 
already reported by other authors, and it has been related to so far unexplained 
toxic effects possibly exerted by abnormal accumulation of this protein 
(Ashbridge et al. 2009). In fact, successful overexpression of a member of this 
protein family has been to date obtained only for archaeal Cbf5p protein from 
Pyrococcus furiosus (Rashid et al. 2006). 
 
Figure 17. Western blot analysis of 3XF-Iso1 selected clones. 
The anti-Flag antibody was used for immunodetection. Numbers on the top mark different 
independent clones. Lanes M: Page ruler ladder (Fermentas). Colored arrows mark the position 
of 100 kDa (green),70 kDa (red) and 40 kDa (yellow) bands of the marker. None of the 
examined clones expressed a fused protein product of the correct size. 
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The selection of 3XF-Iso7 stably transformed clones was instead successful, 
although only 10% of screened clones turned out to be positive. In total, I 
obtained four independent clones to submit to further analyses (see Fig. 18). 
 
Figure 18. Western blot analysis of 3XF-Iso7 selected clones.  
The anti-Flag antibody was used for immunodetection. Numbers on the top mark independently 
isolated  clones. Lanes M: Page ruler ladder. Colored arrows mark the position of 70 kDa (red) 
and 40 kDa (yellow) bands of the marker. Clones 8,15, 40 and 43 all show expression of a 
protein exhibiting the correct size of the iso7-FLAG fused protein. 
As expected, none of the 3XF-mock clones was positive by western analysis. 
Different clones were pooled to get a mean positional effect and used as 
control in the subsequent experiments. 
4.8 MORPHOLOGIC AND CELL-MATRIX ADHESION PROPERTIES 
OF CELLS OVEREXPRESSING ISOFORM 7 
In order to address the biological function -if any- played 
by Isoform 7, stably transformed cells were analyzed for growth, morphology 
and adhesion properties. Four independently isolated clones over-expressing 
Isoform 7 at varying levels (see Fig. 18) were analyzed in these experiments. 
As expected, all these clones showed cytoplasmic localization of the fused 
protein (see Fig. 19 for an example), as previously observed in transiently 
transfected cells. Considering that dyskeratosis is a disorder accompanied by 
abnormal or premature epithelial keratinization, a preliminary inspection of the 
overall cell morphology was performed coloring cells attached to glass by 
Papanicolaou staining, which enables differential staining of nuclei (purple) to 
normal (blue/green) or keratynized cytoplasm (orange). However, no 
significant keratin increment was detected. Instead, I noticed that the 
transformed cells were invariantly characterized by a significant reduction in 
the number and the size of vacuole-like structures respect to the HeLa control 
cells (Fig. 20) which cytoplasm appears to be highly populated by these 
structures. Moreover, in each transformed clone the cells exhibit an increased 
tendency to aggregate to each other (see Figures 20, 21, 22). When the 
transformed cells were visualized under phase contrast microscopy, they again 
showed a tendency of adhere to each other when compared to controls, but also 
exhibited a different morphology, appearing more rounded and less elongated 
(Fig. 21). Intriguingly, changes in morphology and cell adhesion were 
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accompanied by an increased growth rate, indicating that the transformed cells 
also exhibit a growth advantage (see Fig. 21).  
 
Figure 19. Immunolocalization of Isoform 7 in cells from the stably transfected Clone 40.  
In A, immunolocalization of Isoform 7-FLAG fused protein. The signal is absent from the nuclei 
and restricted to cytoplasm. In B, merge of A and nuclear counterstaining with DAPI. 
 
Figure 20. Papanicolaou staining of 3XF-Iso7 transformed and 3XF-mock control cells. 
Typical fields from three 3XF-Iso7 independently transformed clones (15, 43 and 40) are shown. 
In each clone, reduced cytoplasm vacuolization was observed (see also red square areas, 
enlarged in right insets). Images are at 1000X magnification. 
In order to investigate more deeply features typical of these transformed cells, 
sections of cell blocks were stained with Hematoxylin and Eosin, one of the 
most common method to detect a broad range of cytoplasmic, nuclear, and 
extracellular
 
matrix features. Hematoxylin has a deep blue-purple color and
 
stains nucleic acids; eosin is pink and stains proteins nonspecifically. In a 
typical
 
tissue, nuclei are stained blue, whereas the cytoplasm and extracellular
 
matrix have varying degrees of pink staining. This stain discloses abundant
 
structural information, with specific functional implications. When 3XF-Iso7 
cells from independent clones were stained, I observed presence of stretches of 
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adhesed cells forming localized tracts of structured pseudo epithelia that were 
resistant to Versene and trypsin treatments (Fig. 22). The formation of these 
pseudo epithelial rows, never detected in 3XF-mock cell, was again suggestive 
of increased cell adhesivity. Worth noting, this feature is well compatible with 
recent observations that silencing of members of the DKC1 gene family is 
accompanied by reduced cell-cell adhesion (Sieron et al. 2009; Tortoriello et 
al. 2010). 
 
Figure 21. Phase contrast pictures of stably transfected cells. 
In A and B control cells; in B, cell areas rich in vacuole-like structures are black boxed. In 3XF-
Iso7 cells (C and D) vacuole-like structures are strongly reduced; cells from Clone 40 are shown 
as an example. Note the tendency of transformed cells to grow in clusters. Pictures are at 400X 
(left) and 1000X (right) magnification. In E, a comparison of growth curves of 3XF-mock and 
3XF-Iso7 (Clone 40) cells. 
Careful examination of 3XF-Iso7 stained cells also revealed that they were 
characterized by a reduction of the nuclear-cytoplasmic ratio (N/C). Nuclear 
and cytoplasmic areas from 3XF-Iso7 transformed and 3XF-mock control cells 
were measured on acquired images by the ImageJ software. Statistical 
significance of this reduction was confirmed by submitting the values of 
nuclear and cytoplasmic areas from transformed and control cells to one-tailed 
Student's t-test, choosing p<0.01 as threshold. As shown in Table 4, the N/C 
ratio drops off in each independently transformed clone -although at various 
degrees- as consequence of a cytoplasmic enlargement, which is accompanied 
by invariance of the nuclear size. Cell differentiation is often accompanied by 
changes in N/C, with the nucleus retaining its dimension and the cytoplasm 
increasing in size. Conversely, actively proliferating cells show an increase of 
N/C ratio. The higher growth speed displayed by 3XF-Iso7 transformed cells 
would thus contrast with the N/C drop observed. However, cytoplasmic 
swelling has been correlated to higher growth speed also in ras-activated cells, 
where an enhanced proliferative activity has been reported to be accompanied 
by a significant increase in the cytoplasmic volume (Dartsch et al. 1994). 
Although this aspect needs further examination, it is plausible that a set-point 
shift of cell volume regulation, with subsequent cytoplasm swelling, might be 
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due to a rearrangement of the cytoskelatal architecture, of calcium metabolism 
or of volume-regulatory ion transporters, as suggested for ras-activated cells.  
Table 4. Nuclear-cytoplasmic ratio (N/C) of 3XF-Iso7 transformed and 3XF-mock control 
cells  
Cell 
Nuclear  
area (µm
2
)
 
±SD 
(µm
2
)  
Cytoplasmic 
area (µm
2
) 
±SD 
(µm
2
) 
N/C ±SD 
3XF-mock 22.97 7.521 45.19 13.98 0.5515 0.2343 
Clone 8 24.73 9.218 61.26* 23.16 0.4420* 0.2026 
Clone 15 24.72 8.034 58.87* 16.31 0.4414* 0.1701 
Clone 40 23.58 6.926 60.51* 19.14 0.4223* 0.1734 
Clone 43 24.23 7.515 56.86* 14.95 0.4589* 0.2114 
At least 100 cells of each sample were analyzed. * Data showing a p<0.01respect to control by 
one-tailed Student’s t-test. 
Worth noting, AgNOR staining, commonly used to highlight active Nucleolar 
Organizing Regions, did not evidentiate any difference in nuclear size and 
shape, or in the size or the number of the nucleoli (Fig. 23), further supporting 
the general view that the main alterations of transformed cells were restricted 
to the cytoplasm. 
Finally, to further check cell adhesion properties, I performed a cell matrix 
adhesion assay followed by Crystal Violet staining. In this test, a significantly 
greater number of transformed cells quickly adhered to the culture substratum 
respect to the control (Fig. 24), and an increased tendency of cell-cell 
aggregation was observed. All the data obtained are thus consistent with the 
conclusion that Isoform 7 expression influences both cell-cell and cell-
substratum adhesion. Intriguingly, a role for DKC1 in cell adhesion has been 
recently noticed by Sieron et al. (2009), which reported that after RNAi-
mediated gene silencing the cells were characterized by inability to reattach 
after trypsinization, or even spontaneous detachment from the substratum. In 
keeping with these observation, our laboratory recently reported that in-vivo 
RNAi silencing of the DKC1 Drosophila homolog, the mfl/Nop60b gene, 
similarly causes lack of adhesion and defective cell-cell interactions 
(Tortoriello et al. 2010). The data presented here not only confirm a role for 
DKC1 in cell adhesion, but also unrevealed that the novel Isoform 7 is likely to 
participate to this function. Considering the peculiar cytoplasmic localization 
of this variant protein, it is plausible to postulate that it may mediate these 
effects by participating to the IRES-dependent translation or, alternatively, to 
the cytoplasmic transport of snoRNA-derived miRNAs. 
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.  
Figure 22. Hematoxilin Eosin staining of 3XF-Iso7 transformed and 3XF-mock control 
cells.  
Typical fields from three 3XF-Iso7 independently transformed clones (8, 40 and 43) are shown. 
In each clone, structured rows of pseudo epithelia resistant to Versene treatment were 
observed. Images are at magnification 100X (left) and 400X (right). 
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Figure 23. AgNOR staining of 3XF-Iso7 transformed and 3XF-mock control cells.  
Typical fields from three 3XF-Iso7 independently transformed clones (8, 15 and 40) are shown. 
No significant variation in the nuclear (brown/yellow) size or in the nucleolar number or activity 
was observed in the transformed cells. Images are at magnification 400X (left) and 1000X 
(right). 
  
 38 
Figure 24. Cell matrix 
adhesion assay of 3XF-
Iso7 transformed and 
3XF-mock control cells.  
Typical fields from three 
3XF-Iso7 independently 
transformed clones (8, 43, 
and 40) are shown. In 
each clone, a significantly 
greater number of 
transformed cells adhered 
to the substratum respect 
to the control. Increased 
cell-cell aggregation was 
also observed. Images 
are at magnification 100X. 
 
 
 
4.9 SURVIVAL OF 3XF-Iso7 TRANSFORMED CELLS AFTER X-ray 
TREATMENT 
X-ray treatment is known to generate DNA damages, 
which in part are repairable and quickly disappear, and in part are non-
repairable, and thus persist in the cell population with detrimental effects. The 
non-repairable component depends on the dose of X-rays and on its 
subministration rate, since a higher rate corresponds to a higher damage. 
Finally, damage accumulation also depends on the proliferative state of the 
cells, since fast proliferating tissues are more sensitive than slower 
proliferating ones. Given that dyskerin loss-of-function mutations have 
recently been correlated to abnormal response to X-ray like damages (Gu et al. 
2008), I decided to check the X-ray response of 3XF-Iso7 transformed cells. 
Unexpectedly, the dose-response curve to X-ray treatment indicated that these 
cells exhibit an increased repairing potential respect to controls, despite the fact 
that their growth rate was found significantly higher (Fig. 25).  
 
Figure 25. X-ray dose 
response curve of 3XF-Iso7 
transformed and 3XF-mock 
control cells. 
In the curve, the logarithm of the 
number of survived cells is 
plotted against the administered 
dose  
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Transformed and control cells were then analyzed by Crystal Violet staining 
after various doses of X-ray irradiation, i.e. after exposure to 0, 2, 4 and 6 Gy. 
At the 0 dose, a similar colony forming potential was observed for transformed 
and control cells, and the clones formed were of similar size. After the 2 Gy 
treatment, the transformed cells showed a higher percentage of survival and 
were mostly healthy, whereas control cells were often vacuolated and apoptotic 
and mixed to “ghosts” remnants of dead cells. A 4 Gy treatment further 
reduced the density of control clones, whereas the transformed clones were still 
dense but formed by smaller cells, possibly because a high proliferation rate. 
After a 6 Gy treatment, the density of transformed clones was still essentially 
similar to that of non treated cells. In contrast, control clones hardly survived 
and, when present, were very small, being composed of a few and poorly 
stained cells. These data revealed that Isoform 7 exerts a strong effect on X-ray 
response, and possibly on the response to other genotoxic stresses. This result 
is consistent with the previous finding of a DKC1 involvement in the response 
to X-ray-like damages (Gu et al. 2008). The specific cytoplasmic localization 
exhibited by isoform 7 makes its role in the DNA damage response even more 
puzzling, and hints at a less direct role in the DNA repairing mechanisms.  
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Figure 26. Crystal violet 
staining of 3XF-Iso7 
transformed and 3XF-
mock control clones 
after X-ray treatment. 
A) 0 Gy reference point. 
B) Clone survival after 2 
Gy treatment.  
C) Clone survival after 4 
Gy treatment.  
D) Clone survival after 6 
Gy treatment. Images are 
at magnification 25X 
(left), 50X (middle) and 
100X, (right). 
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5 CONCLUSIONS 
The results reported in this thesis revealed that 
transcription of the human DKC1 gene is much more complex than generally 
accepted. Starting from DKC1-related ESTs annotated in the GenBank 
database, I defined the structure of five novel alternatively spliced transcripts 
and validated their effective expression in various cell lines and normal tissues. 
From the structural point of view, all the novel splice variants were 
characterized by retention of specific introns and presence of PTCs. However, 
all escape the NMD mechanism of RNA surveillance, supporting the view that 
they may play specific biological roles. This hypothesis is further supported by 
the finding that they can exhibit different expression profiles during the in-vitro 
differentiation of SK-N-BE(2) cells. Interesting to note, the production of 
isoforms 6 and 7 may antagonize, respectively, the biogenesis of the DKC1 
intron-encoded snoRNAs ACA36 and ACA56. This may have functional 
relevance, since both snoRNAs guide pseudouridylation of specific rRNA 
sites, and ACA56 can also act as miRNA precursor. Strikingly, the novel splice 
variants, with the exception of Isoform 7, all contain short upstream CDSs that 
would miss the C-terminal dyskerin domains, followed by significantly long in 
frame CDSs which, conversely, would miss the N-terminal functional domains. 
This general picture is consistent with the hypothesis that production of DKC1 
alternative isoforms may finely regulate the multiple functional roles played by 
this essential gene.  
Among the novel alternative transcripts, I selected the Isoform 7 for further 
analyses. This isoform attracted my attention mainly on the basis of its coding 
properties and the possibility that, according to a recent case report, it should 
represent the main DKC1 transcript expressed in a male child patient. To gain 
further information on its biological role, this isoform was overexpressed in 
stably transformed HeLa cells. Unexpectedly, the analysis of four 
independently isolated clones revealed that it encodes a variant protein with a 
strictly cytoplasmic localization. Given that dyskerin is an essential component 
of two important nuclear complexes, such as the H/ACA snoRNPs and the 
active telomerase, the role played by this cytoplasmic variant is quite puzzling. 
However, it is plausible that it might participate to ribosome assembly, mRNA 
translation or, alternatively, to cytoplasmic chaperoning of snoRNA-derived 
miRNAs.  
While these aspects remain to be defined, characterization of Isoform 7 
overexpressing clones demonstrated that they exhibit a higher growth rate, 
increased cell-cell and cell-substratum adhesion, and a marked higher tolerance 
to X-ray induced genotoxic damages respect to controls. These results are in 
agreement with functional data deriving from animal model system, and 
indicate that a more exhaustive functional analysis of the DKC1 gene is 
necessary to unrevealing how it may affect a so wide repertoire of fundamental 
cell processes. 
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